ZEN Graphene Solutions Ltd (ZEN) - Cash Flow Conversion Efficiency

Latest as of September 2025: -0.103x

Based on the latest financial reports, ZEN Graphene Solutions Ltd (ZEN) has a cash flow conversion efficiency ratio of -0.103x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CA$-1.21 Million ≈ $-874.48K USD) by net assets (CA$11.69 Million ≈ $8.45 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see ZEN company net worth for the company's overall valuation and market capitalisation.

ZEN Graphene Solutions Ltd - Cash Flow Conversion Efficiency Trend (2010–2025)

This chart illustrates how ZEN Graphene Solutions Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

ZEN Graphene Solutions Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of ZEN Graphene Solutions Ltd ranked by their cash flow conversion efficiency. See debt repayment capacity of ZEN Graphene Solutions Ltd to evaluate how effectively operating cash flow covers total debt obligations.

Company Cash Flow Conversion Efficiency
Jayjun Co Ltd
KO:025620
-0.010x
Wintao Communications Co. Ltd
SHE:301139
0.002x
K Wave Media Ltd.
NASDAQ:KWM
655.501x
NRX Pharmaceuticals Inc
NASDAQ:NRXP
0.112x
Grupo Mexicano de Desarrollo S.A.B
MX:GMD
0.005x
Amarin Printing and Publishing Public Company Limited
BK:AMARIN
0.007x
Emperor Energy Ltd
AU:EMP
-0.062x
Garo AB
ST:GARO
0.070x

Annual Cash Flow Conversion Efficiency for ZEN Graphene Solutions Ltd (2010–2025)

The table below shows the annual cash flow conversion efficiency of ZEN Graphene Solutions Ltd from 2010 to 2025. View current stock price of ZEN Graphene Solutions Ltd for real-time trading data and today's change.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-03-31 CA$14.75 Million
≈ $10.67 Million
CA$-6.28 Million
≈ $-4.54 Million
-0.426x -6.72%
2024-03-31 CA$20.17 Million
≈ $14.59 Million
CA$-8.05 Million
≈ $-5.82 Million
-0.399x +6.40%
2023-03-31 CA$30.38 Million
≈ $21.98 Million
CA$-12.96 Million
≈ $-9.37 Million
-0.426x -84.42%
2022-03-31 CA$34.55 Million
≈ $24.99 Million
CA$-7.99 Million
≈ $-5.78 Million
-0.231x -253.83%
2021-03-31 CA$27.46 Million
≈ $19.87 Million
CA$-1.79 Million
≈ $-1.30 Million
-0.065x -23.88%
2020-03-31 CA$25.71 Million
≈ $18.60 Million
CA$-1.36 Million
≈ $-981.19K
-0.053x -10.97%
2019-03-31 CA$24.90 Million
≈ $18.01 Million
CA$-1.18 Million
≈ $-856.16K
-0.048x -4.95%
2018-03-31 CA$22.07 Million
≈ $15.97 Million
CA$-999.86K
≈ $-723.28K
-0.045x +39.83%
2017-03-31 CA$22.71 Million
≈ $16.43 Million
CA$-1.71 Million
≈ $-1.24 Million
-0.075x +3.96%
2016-03-31 CA$21.45 Million
≈ $15.52 Million
CA$-1.68 Million
≈ $-1.22 Million
-0.078x -28.41%
2015-03-31 CA$20.42 Million
≈ $14.77 Million
CA$-1.25 Million
≈ $-901.60K
-0.061x +46.21%
2014-03-31 CA$21.02 Million
≈ $15.21 Million
CA$-2.39 Million
≈ $-1.73 Million
-0.113x -13.81%
2013-03-31 CA$16.45 Million
≈ $11.90 Million
CA$-1.64 Million
≈ $-1.19 Million
-0.100x +22.61%
2012-03-31 CA$10.23 Million
≈ $7.40 Million
CA$-1.32 Million
≈ $-953.27K
-0.129x -32.33%
2011-03-31 CA$11.14 Million
≈ $8.06 Million
CA$-1.08 Million
≈ $-784.55K
-0.097x -684.51%
2010-03-31 CA$3.04 Million
≈ $2.20 Million
CA$-37.74K
≈ $-27.30K
-0.012x --

About ZEN Graphene Solutions Ltd

V:ZEN Canada Medical Instruments & Supplies
Market Cap
$58.85 Million
CA$81.36 Million CAD
Market Cap Rank
#21389 Global
#750 in Canada
Share Price
CA$0.76
Change (1 day)
-1.30%
52-Week Range
CA$0.54 - CA$1.50
All Time High
CA$7.18
About

Zentek Ltd., together with its subsidiaries, engages in the research and development of graphene and related nanomaterials in Canada. The company develops graphene-based antimicrobial coatings under the ZenGUARD brand, surgical masks, HVAC filters, personal protective equipment, rapid detection point of care diagnostics tests, and pharmaceutical products based on graphene-based compounds. It also… Read more